ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,461.78
      -0.14%
      US Tech 100
      19,177.20
      0.01%
      Dow Jones
      39,071.37
      -0.10%
      Brent Oil
      83.995
      -0.23%
      Bitcoin
      61,281.90
      -0.86%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Theraclion (ALTHE) Quote

      Theraclion

      Theraclion (ALTHE)

      EU
      0.352
      0.007
      ( 2.03% )
      Updated: 11:11:19
      Delayed by 15 minutes

      Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

      Premium

      Key stats and details

      Current Price
      0.352
      Bid
      0.343
      Ask
      0.354
      Volume
      60,490
      0.336 Day's Range 0.37
      0.30 52 Week Range 0.686
      Market Cap
      16.006M
      Previous Close
      0.345
      Open
      0.345
      Last Trade
      500
      @
      0.352
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      33,492
      Shares Outstanding
      45,732,250
      Dividend Yield
      -
      PE Ratio
      -4.35
      Earnings Per Share (EPS)
      -0.08
      Revenue
      3.92M
      Net Profit
      -3.68M

      About Theraclion

      Sector
      Med, Dental, Hosp Eq-whsl
      Industry
      Med, Dental, Hosp Eq-whsl
      Website
      www.theraclion.com
      Headquarters
      Malakoff, Hauts-de-seine, Fra
      Founded
      1970
      Theraclion is listed in the Med, Dental, Hosp Eq-whsl sector of the Euronext with ticker ALTHE. The last closing price for Theraclion was 0.35 €. Over the last year, Theraclion shares have traded in a share price range of 0.30 € to 0.686 €.

      Theraclion currently has 45,732,250 shares outstanding. The market capitalization of Theraclion is 16.01 € million. Theraclion has a price to earnings ratio (PE ratio) of -4.35.

      ALTHE Latest News

      More News

      FeaturedPOET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program

      2 hours ago

      LES TRAITEMENTS DE L'ÉTUDE PIVOT DE LA FDA POUR SONOVEIN® SONT TERMINÉS : THERACLION ATTEINT UNE ÉTAPE CLÉ DANS LES DÉLAIS PRÉVUS

      Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), société innovante développant une plateforme robotique pour la thérapie non invasive par ultrasons focalisés de haute...

      June 24 2024
      Business Wire

      SONOVEIN® MIS EN AVANT LORS DE CONFÉRENCES MÉDICALES DE PREMIER PLAN ET DANS UN JOURNAL SCIENTIFIQUE

      Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), société innovante développant une plateforme robotique pour la thérapie non invasive par ultrasons focalisés de haute intensité...

      June 06 2024
      Business Wire

      THERACLION MET À DISPOSITION SON RAPPORT FINANCIER 2023

      Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), société innovante développant une plateforme robotique pour la thérapie non invasive par ultrasons focalisés de haute intensité...

      April 25 2024
      Business Wire

      THERACLION ANNONCE SES RÉSULTATS FINANCIERS 2023 ET POURSUIT SA FEUILLE DE ROUTE

      Poursuite de la stratégie centrée sur les accès aux marchés américain et chinois pour le SONOVEIN®, et à son amélioration grâce à la R&D ; Démarrage rapide de l’étude pivot aux Etats-Unis :...

      March 27 2024
      Business Wire

      Theraclion Pursues Its Strategy and Announces Its 2023 Revenue

      Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), an innovative company developing a scalable robotic platform for non-invasive focused ultrasound therapy (HIFU...

      January 29 2024
      Business Wire

      THERACLION ATTEINT SES OBJECTIFS STRATÉGIQUES 2023

      Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE), société innovante développant une plateforme robotique pour l'échothérapie non invasive, dresse aujourd’hui le bilan de ses...

      December 14 2023
      Business Wire

      Theraclion Achieves an Important Milestone on the Road to the U.S. Market: First Patients Treated With SONOVEIN® as Part of the FDA-approved Pivotal Study

      Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), an innovative company developing a scalable robotic platform for non-invasive ultrasound therapy, announced today...

      October 24 2023
      Business Wire

      THERACLION ANNONCE SES RÉSULTATS FINANCIERS SEMESTRIELS 2023 ET FAIT LE POINT SUR L’EXÉCUTION DE SA STRATÉGIE

      Regulatory News: THERACLION (ISIN: FR0010120402; Mnemo: ALTHE) (Paris:ALTHE), société innovante développant une plateforme robotique pour l'échothérapie non invasive, présente ses résultats...

      October 11 2023
      Business Wire
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.0051.44092219020.3470.370.33687000.34415382DE
      4-0.022-5.882352941180.3740.4270.33464480.35858518DE
      12-0.036-9.278350515460.3880.570.33334920.38987561DE
      26-0.002-0.5649717514120.3540.680.308307270.41399891DE
      52-0.258-42.29508196720.610.6860.3232630.42841573DE
      156-1.453-80.49861495841.8052.220.3195020.85474361DE
      260-0.708-66.79245283021.062.760.3204751.1757188DE

      Market Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      OPTXSyntec Optics Holdings Inc
      $ 6.34
      (169.79%)
      		26.63M
      WENAANEW MEDICAL INC
      $ 3.9299
      (138.18%)
      		69.03M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.4501
      (69.85%)
      		437.05M
      CMAXCareMax Inc
      $ 2.8409
      (49.52%)
      		478.32k
      AIEVThunder Power Holdings Inc
      $ 2.36
      (37.21%)
      		27.82M
      CNSPCNS Pharmaceuticals Inc
      $ 1.68
      (-40.85%)
      		1.12M
      NUWENewellis Inc
      $ 0.1315
      (-39.62%)
      		7.84M
      GRIGRI Bio Inc
      $ 1.83
      (-38.38%)
      		544.4k
      LYELLyell Immunopharma Inc
      $ 1.3192
      (-35.33%)
      		5.14M
      RELIReliance Global Group Inc
      $ 0.2836
      (-28.58%)
      		5.11M
      FFIEFaraday Future Intelligent Electric Inc
      $ 0.4501
      (69.85%)
      		437.05M
      NVDANVIDIA Corporation
      $ 123.81
      (-1.81%)
      		168.23M
      RIVNRivian Automotive Inc
      $ 15.385
      (28.64%)
      		151.22M
      WENAANEW MEDICAL INC
      $ 3.9299
      (138.18%)
      		69.03M
      SQQQProShares UltraPro Short QQQ
      $ 8.22
      (-2.03%)
      		49.39M

      Discussion

      View Full Feed
      CMsixfigures CMsixfigures 5 minutes ago
      $ICTY VERY BULLISH LOAD AND HOLD
      https://stockta.com/cgi-bin/analysis.pl?symb=ICTY&cobrand=&mode=stock
      ICTY
      vlispxpert vlispxpert 5 minutes ago
      Interesting chart yesterday, even more so today:

      https://schrts.co/qgBkGHyt
      meirluc meirluc 5 minutes ago
      GeorgeB, SurVaxM is administered subcutaneously in the arms or legs
      and a Eden's automated system would therefore not be used to
      administer this treatment. I am thinking that if the cost of SurVaxM is
      reasonable why not try it with DCVax-L and polyICLC in a combo
      tr
      NWBO
      dreamaker56 dreamaker56 5 minutes ago
      Good! Thanks! I don't have twitter which is probably good because he would block me at this point.
      BLEG
      newman2021 newman2021 5 minutes ago
      without getting proper education, you are fooling yourself and others. Yes, who are you protecting? No 40c for you, ok?
      NWBO
      Donotunderstand Donotunderstand 5 minutes ago
      is that it ?

      could be

      I did look up Rivian income and it is seriously - and more - larger than NKLA

      but -- if NKLA has the factory and distribution and HYLA and ...and software and ... and .... I would gladly (without doing the math) welcome say 1B (v 4B)
      NKLA
      CaptBeer CaptBeer 6 minutes ago
      All of these cases could be avoided by two words: Our product is “indicated for” …..
      AMRN
      DR_rugby DR_rugby 6 minutes ago
      Interesting data composition

      https://m.youtube.com/watch?v=DMjO5jZ_Qko

      CS report findings

      https://www.credit-suisse.com/media/assets/corporate/docs/about-us/investor-relations/financial-disclosures/results/csg-special-committee-bod-report-archegos.pdf
      GME
      DR_rugby DR_rugby 6 minutes ago
      Interesting data composition

      https://m.youtube.com/watch?v=DMjO5jZ_Qko

      CS report findings

      https://www.credit-suisse.com/media/assets/corporate/docs/about-us/investor-relations/financial-disclosures/results/csg-special-committee-bod-report-archegos.pdf
      GME
      PioneerEmpire67 PioneerEmpire67 6 minutes ago
      I agree with mc73. The only market manipulator at this point is Vivos itself. Get ready for a free fall.
      RDGL
      Timing101 Timing101 6 minutes ago
      Well you are doing quite the followup on many items, thanks for that.
      --
      I do believe at this point Chandra said ALOT in his most recent Posting . WE is a strong statement, not just Chandra. Also discussion where they are headed with Proprietary AI, Information, Platforms coming ou
      ENZC
      DJ Ponder DJ Ponder 6 minutes ago
      The guys a freakin imbecile.
      Hilarious

      Smh.
      ASTA
      CMsixfigures CMsixfigures 7 minutes ago
      $ICTY WEAK HANDS LEAVING @ T5 STRONGER HANDS MOVING IN

      https://stocktwits.com/symbol/ICTY
      ICTY
      HendrikInv HendrikInv 7 minutes ago
      I only take advice from other millionaires.
      CATV
      Jeremyan7 Jeremyan7 7 minutes ago
      I think you may be confusing revenue (top line) with income (bottom line or profit). The $5 million number was top line so there is and was never expectation for that to be “pure profit”. In terms of what anyone here expects them to do in terms of future revenue or exit strategy. Anything anyone her
      UBQU
      learningcurve2020 learningcurve2020 7 minutes ago
      They intend to convert the 2b into a pivotal study so I'd expect it to move quickly monitoring for PFS. It's a shame they need to include SOC with this treatment. The real winner is one without surgery and chemo, obviously.
      NWBO
      Propain Propain 7 minutes ago
      I bought some shares about 30 minutes ago. Thats what caused the down turn. Sorry. I kill stocks every time I buy.
      WENA
      Jp_SHMP Jp_SHMP 8 minutes ago
      another 4-5 months with 7 mores entities inside the new ticher $JFHE incoming

      300M users next years

      I'am talking multiple billions in the making

      My dream is coming true......... near future 2-3 years

      using the stock for equities is genius $
      IGPK JFHE
      nidan7500 nidan7500 8 minutes ago
      Expect a new corporate presentation tomorrow with June 2024 updates.georgejji

      You left out an important qualifier....FINALLY.......THANK YOU ...looking fwd to this update
      AVXL
      CMsixfigures CMsixfigures 8 minutes ago
      $ICTY VERY BULLSIH BREAKOUT IS NEAR STAY TUNED
      https://www.stockscores.com/charts/charts/?ticker=icty
      ICTY
      keepsinvesting keepsinvesting 8 minutes ago
      They gonna squeeze these guys during lunch im assuming
      FREE_DONUTS FREE_DONUTS 8 minutes ago
      ABOMINABLE SNOWMAN
      CRKN

      Your Recent History

      EU
      ALTHE
      Theraclion
      NASDAQ
      MSDA
      MSD Acquisition
      AMEX
      STCE
      Schwab Crypto Thematic ETF
      Delayed Upgrade Clock